LabCorp

LabCorp Loses $317M as Test Demand Slumps
Financial Performance

LabCorp Loses $317M as Test Demand Slumps

“During the first quarter, both diagnostics and drug development began experiencing the impact of the global pandemic," CEO Adam Schecter says.
By Matthew Heller | April 30, 2020
Read More
LabCorp Hit by Ransomware But No Data Stolen
Technology

LabCorp Hit by Ransomware But No Data Stolen

The strain of ransomware that was reportedly used in the attack on LabCorp can "effectively lock down a computer, encrypting all the files inside."
By Matthew Heller | July 20, 2018
Read More
LabCorp Buys U.K. Biopharma Services Firm
Strategy

LabCorp Buys U.K. Biopharma Services Firm

The $1.2 billion acquisition of Chiltern continues a wave of consolidation in the contract research organization industry.
By Matthew Heller | July 31, 2017
Read More